ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
Sweden · Delayed Price · Currency is SEK 1.125
-0.055 (-4.66%)
Sep 24, 2026, 4:46 PM CET
STO:EXPRS2 Market Cap
STO:EXPRS2 has a market cap or net worth of 26.72 million as of September 24, 2026. Its market cap has decreased by -41.90% in one year.
Market Cap
26.72M
Enterprise Value
-6.21M
Revenue
24.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.13
ChartMarket Cap Chart
Since July 29, 2016, STO:EXPRS2's market cap has decreased from 117.71M to 26.72M, a decrease of -77.30%. That is a compound annual growth rate of -13.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 26.72M | -52.40% |
| Dec 30, 2025 | 56.13M | 29.73% |
| Dec 30, 2024 | 43.27M | -60.11% |
| Dec 29, 2023 | 108.46M | -82.55% |
| Dec 30, 2022 | 621.64M | -45.72% |
| Dec 30, 2021 | 1.15B | 280.55% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pila Pharma AB | 85.43M |
| Ascelia Pharma AB | 81.19M |
| Spago Nanomedical AB | 78.08M |
| Annexin Pharmaceuticals AB | 71.30M |
| AcouSort AB | 65.82M |
| Modus Therapeutics Holding AB | 58.74M |
| OncoZenge AB | 46.64M |
| Fluicell AB | 41.76M |